-
"The Fentanyl Project," which focuses on two families dealing with the losses of loved ones, highlights how counterfeit prescription pills are causing fentanyl deaths to skyrocket. We talk with the director.
-
After years of work, a little-known advisory committee has submitted its recommendation to county commissioners on how to spend $148 million over 20 years from opioid lawsuit settlements.
-
The Miami-Dade County School Board has filed a federal lawsuit against more than a dozen corporations that manufacture or distribute opioids, claiming...
-
The agreement removes the drugmaker from the list of defendants in an upcoming federal opioid trial and follows an August settlement in Oklahoma in which it agreed to pay $572 million.
-
A measure that would allow attorneys for the state to have access to a prescription-drug database as they pursue a lawsuit against the pharmaceutical…
-
Duval County has the highest per capita heroin and fentanyl related death rate of any county in Florida, but an opioid program is curbing the epidemic...
-
Attorneys who represent hundreds of local governments have a new proposal for how to deal with the opioid crisis. They unveiled the framework for nationwide settlement in federal court on Friday.
-
The maker of a highly addictive fentanyl-based drug wants to sell its assets to pay some $250 million in debts. The move could let the company out of part of the settlement deal reached last week.
-
The company agreed to make the payments to resolve federal criminal and civil investigations of its marketing practices. Five of its executives were convicted separately for the same practices.
-
The agency that manages health care for California’s massive state workforce is reporting a major reduction in opioid prescriptions, reflecting a national…
-
The federal government accused John Kapoor, the founder of Insys Therapeutics, and his co-defendants of running a nationwide bribery scheme that contributed to the opioid crisis.
-
The House on Monday unanimously approved a bill that would give the attorney general access to information in a state prescription-drug database that…